Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
Original Article
T. Munir, S. Girvan, D.A. Cairns, A. Bloor, D. Allsup, A.M. Varghese, S. Gohil, S. Paneesha, A. Pettitt, T. Eyre, C.P. Fox, F. Forconi, B. Kennedy, C. Balotis, N. Pemberton, O. Sheehy, J. Gribben, N. Elmusharaf, S. Gatto, G. Preston, A. Schuh, R. Walewska, L. Duley, N. Webster, S. Dalal, A. Rawstron, D. Howard, A. Hockaday, S. Jackson, N. Greatorex, S. Bell, D. Stones, J.M. Brown, P.E. Patten, and P. Hillmen
N Engl J Med 2025;393:1177-1190
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.